Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
In Vitro DiagnosticsBiotechnology Equipment

PUBLISHER: Grand View Research | PRODUCT CODE: 2017821

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 2017821

Activated Clotting Time Testing Market Size, Share & Trends Analysis Report By Product, By Test Type, By Application, By End-use, By Region, And Segment Forecasts, 2026 - 2033

PUBLISHED:
PAGES: 120 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 5950
Printable PDF & Excel (5-User License)
USD 6950
Printable PDF & Excel (Enterprise License)
USD 8950

Add to Cart

Description

Table of Contents

List of Tables

Activated Clotting Time Testing Market Summary

The global activated clotting time testing market size was estimated at USD 1.19 billion in 2025 and is projected to reach USD 2.13 billion by 2033, growing at a CAGR of 7.6% from 2026 to 2033. The growth of the market is driven by the increasing cardiovascular disease prevalence, growing adoption of point of care diagnostics, and a steady increase in the number of surgical procedures particularly minimally invasive surgeries.

In addition, the expanding use of dialysis and extracorporeal membrane oxygenation (ECMO) procedures is contributing to sustained market demand. Activated Clotting Time (ACT) testing is extensively used across hospitals, cardiac catheterization laboratories, and critical care units to enable real-time monitoring of anticoagulation during complex procedures. Clinical data suggests that ACT tests are frequently performed in operating rooms during cardiac surgeries (32.4%) and cardiac catheterization procedures (32.3%), highlighting its strong and widespread clinical adoption.

The rising global burden of cardiovascular diseases, including coronary artery disease, myocardial infarction, and thrombosis, is a key driver of growth in the ACT testing market. These conditions frequently require surgical and interventional procedures such as cardiac catheterization, angioplasty, and cardiopulmonary bypass, where effective anticoagulation management is critical. During these procedures, patients are administered high doses of anticoagulants, particularly heparin, to prevent thrombus formation within blood vessels and medical devices. However, maintaining the optimal balance of anticoagulation is essential, as excessive dosing can lead to severe bleeding complications. As a result, ACT testing is widely utilized to provide a rapid, real-time assessment of clotting time, enabling clinicians to monitor and adjust anticoagulation therapy effectively.

With the increasing prevalence of cardiovascular diseases globally, there has been a corresponding rise in the volume of cardiac surgeries and interventional procedures. This trend is directly driving demand for ACT testing devices and consumables across hospitals and cardiac catheterization laboratories. For instance, according to the World Health Organization (WHO), global cardiovascular disease cases increased from approximately 311 million in 1990 to around 626 million in 2023, resulting in nearly 19.8 million deaths annually. This increasing disease burden continues to strengthen the need for reliable anticoagulation monitoring solutions, thereby supporting sustained growth in the ACT testing market.

The growing adoption of point-of-care (POC) diagnostics is a key factor driving the market, as it enables rapid bedside testing and faster clinical decision-making. POC ACT testing allows real-time monitoring of anticoagulation during procedures such as surgeries, dialysis, and ECMO, enabling clinicians promptly adjust anticoagulant dosing and reduce the risk of bleeding or clotting complications. Its ability to improve workflow efficiency, minimize sample transport, and support minimally invasive procedures has further accelerated its use. As healthcare systems increasingly shift toward decentralized diagnostics, demand for portable and automated ACT testing devices continues to rise, supported by the growing adoption of advanced systems such as the i-STAT platform in operating room settings.

Global Activated Clotting Time Testing Market Report Segmentation

This report forecasts revenue growth at country levels and provides an analysis on the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global activated clotting time testing market report on the basis of product, test type, application, end-use, and region:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • ACT Analyzers
  • Consumables (Cartridges, Tubes, Reagents)
  • Test Type Outlook (Revenue, USD Million, 2021 - 2033)
  • High-Range ACT Tests
  • Low-Range ACT Tests
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Cardiovascular Surgery
  • Interventional Cardiology
  • Extracorporeal Membrane Oxygenation (ECMO)
  • Hemodialysis
  • Others
  • End-use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospital
  • Ambulatory Surgical Centers
  • Clinical Laboratories
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Norway
    • Denmark
    • Sweden
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Argentina
    • Rest of Latin America
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait
    • Rest of Middle East & Africa
Show more
Product Code: GVR-4-68040-879-9

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Test Type
    • 1.2.3. Application
    • 1.2.4. End Use
    • 1.2.5. Regional Scope
    • 1.2.6. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Regional outlook
  • 2.4. Competitive Insights

Chapter 3. Activated Clotting Time Testing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing cardiovascular disease prevalence
      • 3.2.1.2. Technological advancement and growing adoption of point of care diagnostics
      • 3.2.1.3. Increasing number of surgical procedures
      • 3.2.1.4. Expansion of dialysis and ECMO procedures
      • 3.2.1.5. Growth in minimally invasive surgeries
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High cost
      • 3.2.2.2. Shortage of skilled professionals
  • 3.3. Activated Clotting Time Testing Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape

Chapter 4. Activated Clotting Time Testing Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Activated Clotting Time Testing Market: Product Movement Analysis
  • 4.3. Activated Clotting Time Testing Market by Product Outlook (USD Million)
  • 4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 4.5. ACT Analyzers
    • 4.5.1. ACT Analyzers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Consumables (Cartridges, Tubes, Reagents)
    • 4.6.1. Consumables (Cartridges, Tubes, Reagents) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Activated Clotting Time Testing Market: Test Type Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Activated Clotting Time Testing Market: Test Type Movement Analysis
  • 5.3. Activated Clotting Time Testing Market by Test Type Outlook (USD Million)
  • 5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 5.5. High-Range ACT Tests
    • 5.5.1. High-Range ACT Tests Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Low-Range ACT Tests
    • 5.6.1. Low-Range ACT Tests Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Activated Clotting Time Testing Market: Application Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Activated Clotting Time Testing Market: Application Movement Analysis
  • 6.3. Activated Clotting Time Testing Market by Application Outlook (USD Million)
  • 6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 6.5. Cardiovascular Surgery
    • 6.5.1. Cardiovascular Surgery Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Interventional Cardiology
    • 6.6.1. Interventional Cardiology Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7. Extracorporeal Membrane Oxygenation (ECMO)
    • 6.7.1. Extracorporeal Membrane Oxygenation (ECMO) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.8. Hemodialysis
    • 6.8.1. Hemodialysis Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.9. Others
    • 6.9.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Activated Clotting Time Testing Market: End Use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Activated Clotting Time Testing Market: End Use Movement Analysis
  • 7.3. Activated Clotting Time Testing Market by End Use Outlook (USD Million)
  • 7.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 7.5. Hospitals
    • 7.5.1. Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Ambulatory Surgical Centers
    • 7.6.1. Ambulatory Surgical Centers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7. Clinical Laboratories
    • 7.7.1. Clinical Laboratories Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.8. Others
    • 7.8.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Activated Clotting Time Testing Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Dashboard
  • 8.2. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
  • 8.3. North America
    • 8.3.1. U.S.
      • 8.3.1.1. Key country dynamics
      • 8.3.1.2. Regulatory framework/ reimbursement structure
      • 8.3.1.3. Competitive scenario
      • 8.3.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.3.2. Canada
      • 8.3.2.1. Key country dynamics
      • 8.3.2.2. Regulatory framework/ reimbursement structure
      • 8.3.2.3. Competitive scenario
      • 8.3.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.3.3. Mexico
      • 8.3.3.1. Key country dynamics
      • 8.3.3.2. Regulatory framework/ reimbursement structure
      • 8.3.3.3. Competitive scenario
      • 8.3.3.4. Mexico market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.4. Europe
    • 8.4.1. UK
      • 8.4.1.1. Key country dynamics
      • 8.4.1.2. Regulatory framework/ reimbursement structure
      • 8.4.1.3. Competitive scenario
      • 8.4.1.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.4.2. Germany
      • 8.4.2.1. Key country dynamics
      • 8.4.2.2. Regulatory framework/ reimbursement structure
      • 8.4.2.3. Competitive scenario
      • 8.4.2.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.4.3. France
      • 8.4.3.1. Key country dynamics
      • 8.4.3.2. Regulatory framework/ reimbursement structure
      • 8.4.3.3. Competitive scenario
      • 8.4.3.4. France market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.4.4. Italy
      • 8.4.4.1. Key country dynamics
      • 8.4.4.2. Regulatory framework/ reimbursement structure
      • 8.4.4.3. Competitive scenario
      • 8.4.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.4.5. Spain
      • 8.4.5.1. Key country dynamics
      • 8.4.5.2. Regulatory framework/ reimbursement structure
      • 8.4.5.3. Competitive scenario
      • 8.4.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.4.6. Norway
      • 8.4.6.1. Key country dynamics
      • 8.4.6.2. Regulatory framework/ reimbursement structure
      • 8.4.6.3. Competitive scenario
      • 8.4.6.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.4.7. Sweden
      • 8.4.7.1. Key country dynamics
      • 8.4.7.2. Regulatory framework/ reimbursement structure
      • 8.4.7.3. Competitive scenario
      • 8.4.7.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.4.8. Denmark
      • 8.4.8.1. Key country dynamics
      • 8.4.8.2. Regulatory framework/ reimbursement structure
      • 8.4.8.3. Competitive scenario
      • 8.4.8.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.4.9. Rest of Europe
      • 8.4.9.1. Key country dynamics
      • 8.4.9.2. Regulatory framework/ reimbursement structure
      • 8.4.9.3. Competitive scenario
      • 8.4.9.4. Rest of Europe market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.5. Asia Pacific
    • 8.5.1. Japan
      • 8.5.1.1. Key country dynamics
      • 8.5.1.2. Regulatory framework/ reimbursement structure
      • 8.5.1.3. Competitive scenario
      • 8.5.1.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.5.2. China
      • 8.5.2.1. Key country dynamics
      • 8.5.2.2. Regulatory framework/ reimbursement structure
      • 8.5.2.3. Competitive scenario
      • 8.5.2.4. China market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.5.3. India
      • 8.5.3.1. Key country dynamics
      • 8.5.3.2. Regulatory framework/ reimbursement structure
      • 8.5.3.3. Competitive scenario
      • 8.5.3.4. India market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.5.4. Australia
      • 8.5.4.1. Key country dynamics
      • 8.5.4.2. Regulatory framework/ reimbursement structure
      • 8.5.4.3. Competitive scenario
      • 8.5.4.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.5.5. South Korea
      • 8.5.5.1. Key country dynamics
      • 8.5.5.2. Regulatory framework/ reimbursement structure
      • 8.5.5.3. Competitive scenario
      • 8.5.5.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.5.6. Thailand
      • 8.5.6.1. Key country dynamics
      • 8.5.6.2. Regulatory framework/ reimbursement structure
      • 8.5.6.3. Competitive scenario
      • 8.5.6.4. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.5.7. Rest of Asia Pacific
      • 8.5.7.1. Key country dynamics
      • 8.5.7.2. Regulatory framework/ reimbursement structure
      • 8.5.7.3. Competitive scenario
      • 8.5.7.4. Rest of Asia Pacific market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.6. Latin America
    • 8.6.1. Brazil
      • 8.6.1.1. Key country dynamics
      • 8.6.1.2. Regulatory framework/ reimbursement structure
      • 8.6.1.3. Competitive scenario
      • 8.6.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.6.2. Argentina
      • 8.6.2.1. Key country dynamics
      • 8.6.2.2. Regulatory framework/ reimbursement structure
      • 8.6.2.3. Competitive scenario
      • 8.6.2.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.6.3. Rest of Latin America
      • 8.6.3.1. Key country dynamics
      • 8.6.3.2. Regulatory framework/ reimbursement structure
      • 8.6.3.3. Competitive scenario
      • 8.6.3.4. Rest of Latin America market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.7. MEA
    • 8.7.1. South Africa
      • 8.7.1.1. Key country dynamics
      • 8.7.1.2. Regulatory framework/ reimbursement structure
      • 8.7.1.3. Competitive scenario
      • 8.7.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.7.2. Saudi Arabia
      • 8.7.2.1. Key country dynamics
      • 8.7.2.2. Regulatory framework/ reimbursement structure
      • 8.7.2.3. Competitive scenario
      • 8.7.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.7.3. UAE
      • 8.7.3.1. Key country dynamics
      • 8.7.3.2. Regulatory framework/ reimbursement structure
      • 8.7.3.3. Competitive scenario
      • 8.7.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.7.4. Kuwait
      • 8.7.4.1. Key country dynamics
      • 8.7.4.2. Regulatory framework/ reimbursement structure
      • 8.7.4.3. Competitive scenario
      • 8.7.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.7.5. Rest of MEA
      • 8.7.5.1. Key country dynamics
      • 8.7.5.2. Regulatory framework/ reimbursement structure
      • 8.7.5.3. Competitive scenario
      • 8.7.5.4. Rest of MEA market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Market Participant Categorization
  • 9.2. Recent Developments & Impact Analysis by Key Market Participants
  • 9.3. Company Market Share Analysis, 2025
  • 9.4. Key Company Profiles
    • 9.4.1. Werfen
      • 9.4.1.1. Company overview
      • 9.4.1.2. Financial performance
      • 9.4.1.3. Product benchmarking
      • 9.4.1.4. Strategic initiatives
    • 9.4.2. Medtronic
      • 9.4.2.1. Company overview
      • 9.4.2.2. Financial performance
      • 9.4.2.3. Product benchmarking
      • 9.4.2.4. Strategic initiatives
    • 9.4.3. Helena Laboratories Corporation
      • 9.4.3.1. Company overview
      • 9.4.3.2. Financial performance
      • 9.4.3.3. Product benchmarking
      • 9.4.3.4. Strategic initiatives
    • 9.4.4. Abbott
      • 9.4.4.1. Company overview
      • 9.4.4.2. Financial performance
      • 9.4.4.3. Product benchmarking
      • 9.4.4.4. Strategic initiatives
    • 9.4.5. Sienco, Inc.
      • 9.4.5.1. Company overview
      • 9.4.5.2. Financial performance
      • 9.4.5.3. Product benchmarking
      • 9.4.5.4. Strategic initiatives
    • 9.4.6. F. Hoffmann-La Roche Ltd
      • 9.4.6.1. Company overview
      • 9.4.6.2. Financial performance
      • 9.4.6.3. Product benchmarking
      • 9.4.6.4. Strategic initiatives
    • 9.4.7. Sysmex Corporation
      • 9.4.7.1. Company overview
      • 9.4.7.2. Financial performance
      • 9.4.7.3. Product benchmarking
      • 9.4.7.4. Strategic initiatives
    • 9.4.8. Danaher Corporation
      • 9.4.8.1. Company overview
      • 9.4.8.2. Financial performance
      • 9.4.8.3. Product benchmarking
      • 9.4.8.4. Strategic initiatives
    • 9.4.9. Thermo Fisher Scientific Inc.
      • 9.4.9.1. Company overview
      • 9.4.9.2. Financial performance
      • 9.4.9.3. Product benchmarking
      • 9.4.9.4. Strategic initiatives
    • 9.4.10. Siemens Healthineers AG., Ltd.
      • 9.4.10.1. Company overview
      • 9.4.10.2. Financial performance
      • 9.4.10.3. Product benchmarking
      • 9.4.10.4. Strategic initiatives
    • 9.4.11. SEKISUI Diagnostics
      • 9.4.11.1. Company overview
      • 9.4.11.2. Financial performance
      • 9.4.11.3. Product benchmarking
      • 9.4.11.4. Strategic initiatives
Show more
Product Code: GVR-4-68040-879-9

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Activated Clotting Time Testing market, by Product, 2021 - 2033 (USD Million)
  • Table 4 Global Activated Clotting Time Testing market, by Test Type, 2021 - 2033 (USD Million)
  • Table 5 Global Activated Clotting Time Testing market, by Application, 2021 - 2033 (USD Million)
  • Table 6 Global Activated Clotting Time Testing market, by End Use, 2021 - 2033 (USD Million)
  • Table 7 Global Activated Clotting Time Testing market, by Region, 2021 - 2033 (USD Million)
  • Table 8 North America Activated Clotting Time Testing market, Country, 2021 - 2033 (USD Million)
  • Table 9 North America Activated Clotting Time Testing market, by Product, 2021 - 2033 (USD Million)
  • Table 10 North America Activated Clotting Time Testing market, by Test Type, 2021 - 2033 (USD Million)
  • Table 11 North America Activated Clotting Time Testing market, by Application, 2021 - 2033 (USD Million)
  • Table 12 North America Activated Clotting Time Testing market, by End Use, 2021 - 2033 (USD Million)
  • Table 13 U.S. Activated Clotting Time Testing market, by Product, 2021 - 2033 (USD Million)
  • Table 14 U.S. Activated Clotting Time Testing market, by Test Type, 2021 - 2033 (USD Million)
  • Table 15 U.S. Activated Clotting Time Testing market, by Application, 2021 - 2033 (USD Million)
  • Table 16 U.S. Activated Clotting Time Testing market, by End Use, 2021 - 2033 (USD Million)
  • Table 17 Canada Activated Clotting Time Testing market, by Product, 2021 - 2033 (USD Million)
  • Table 18 Canada Activated Clotting Time Testing market, by Test Type, 2021 - 2033 (USD Million)
  • Table 19 Canada Activated Clotting Time Testing market, by Application, 2021 - 2033 (USD Million)
  • Table 20 Canada Activated Clotting Time Testing market, by End Use, 2021 - 2033 (USD Million)
  • Table 21 Mexico Activated Clotting Time Testing market, by Product, 2021 - 2033 (USD Million)
  • Table 22 Mexico Activated Clotting Time Testing market, by Test Type, 2021 - 2033 (USD Million)
  • Table 23 Mexico Activated Clotting Time Testing market, by Application, 2021 - 2033 (USD Million)
  • Table 24 Mexico Activated Clotting Time Testing market, by End Use, 2021 - 2033 (USD Million)
  • Table 25 Europe Activated Clotting Time Testing market, by Country, 2021 - 2033 (USD Million)
  • Table 26 Europe Activated Clotting Time Testing market, by Product, 2021 - 2033 (USD Million)
  • Table 27 Europe Activated Clotting Time Testing market, by Test Type, 2021 - 2033 (USD Million)
  • Table 28 Europe Activated Clotting Time Testing market, by Application, 2021 - 2033 (USD Million)
  • Table 29 Europe Activated Clotting Time Testing market, by End Use, 2021 - 2033 (USD Million)
  • Table 30 UK Activated Clotting Time Testing market, by Product, 2021 - 2033 (USD Million)
  • Table 31 UK Activated Clotting Time Testing market, by Test Type, 2021 - 2033 (USD Million)
  • Table 32 UK Activated Clotting Time Testing market, by Application, 2021 - 2033 (USD Million)
  • Table 33 UK Activated Clotting Time Testing market, by End Use, 2021 - 2033 (USD Million)
  • Table 34 Germany Activated Clotting Time Testing market, by Product, 2021 - 2033 (USD Million)
  • Table 35 Germany Activated Clotting Time Testing market, by Test Type, 2021 - 2033 (USD Million)
  • Table 36 Germany Activated Clotting Time Testing market, by Application 2021 - 2033 (USD Million)
  • Table 37 Germany Activated Clotting Time Testing market, by End Use, 2021 - 2033 (USD Million)
  • Table 38 France Activated Clotting Time Testing market, by Product, 2021 - 2033 (USD Million)
  • Table 39 France Activated Clotting Time Testing market, by Test Type, 2021 - 2033 (USD Million)
  • Table 40 France Activated Clotting Time Testing market, by Application 2021 - 2033 (USD Million)
  • Table 41 France Activated Clotting Time Testing market, by End Use, 2021 - 2033 (USD Million)
  • Table 42 Italy Activated Clotting Time Testing market, by Product, 2021 - 2033 (USD Million)
  • Table 43 Italy Activated Clotting Time Testing market, by Test Type, 2021 - 2033 (USD Million)
  • Table 44 Italy Activated Clotting Time Testing market, by Application, 2021 - 2033 (USD Million)
  • Table 45 Italy Activated Clotting Time Testing market, by End Use, 2021 - 2033 (USD Million)
  • Table 46 Spain Activated Clotting Time Testing market, by Product, 2021 - 2033 (USD Million)
  • Table 47 Spain Activated Clotting Time Testing market, by Test Type, 2021 - 2033 (USD Million)
  • Table 48 Spain Activated Clotting Time Testing market, by Application, 2021 - 2033 (USD Million)
  • Table 49 Spain Activated Clotting Time Testing market, by End Use, 2021 - 2033 (USD Million)
  • Table 50 Denmark Activated Clotting Time Testing market, by Product, 2021 - 2033 (USD Million)
  • Table 51 Denmark Activated Clotting Time Testing market, by Test Type, 2021 - 2033 (USD Million)
  • Table 52 Denmark Activated Clotting Time Testing market, by Application 2021 - 2033 (USD Million)
  • Table 53 Denmark Activated Clotting Time Testing market, by End Use, 2021 - 2033 (USD Million)
  • Table 54 Sweden Activated Clotting Time Testing market, by Product, 2021 - 2033 (USD Million)
  • Table 55 Sweden Activated Clotting Time Testing market, by Test Type, 2021 - 2033 (USD Million)
  • Table 56 Sweden Activated Clotting Time Testing market, by Application, 2021 - 2033 (USD Million)
  • Table 57 Sweden Activated Clotting Time Testing market, by End Use, 2021 - 2033 (USD Million)
  • Table 58 Norway Activated Clotting Time Testing market, by Product, 2021 - 2033 (USD Million)
  • Table 59 Norway Activated Clotting Time Testing market, by Test Type, 2021 - 2033 (USD Million)
  • Table 60 Norway Activated Clotting Time Testing market, by Application, 2021 - 2033 (USD Million)
  • Table 61 Norway Activated Clotting Time Testing market, by End Use, 2021 - 2033 (USD Million)
  • Table 62 Rest of Europe Activated Clotting Time Testing market, by Product, 2021 - 2033 (USD Million)
  • Table 63 Rest of Europe Activated Clotting Time Testing market, by Test Type, 2021 - 2033 (USD Million)
  • Table 64 Rest of Europe Activated Clotting Time Testing market, by Application, 2021 - 2033 (USD Million)
  • Table 65 Rest of Europe Activated Clotting Time Testing market, by End Use, 2021 - 2033 (USD Million)
  • Table 66 Asia Pacific Activated Clotting Time Testing market, by Country, 2021 - 2033 (USD Million)
  • Table 67 Asia Pacific Activated Clotting Time Testing market, by Product, 2021 - 2033 (USD Million)
  • Table 68 Asia Pacific Activated Clotting Time Testing market, by Test Type, 2021 - 2033 (USD Million)
  • Table 69 Asia Pacific Activated Clotting Time Testing market, by Application, 2021 - 2033 (USD Million)
  • Table 70 Asia Pacific Activated Clotting Time Testing market, by End Use, 2021 - 2033 (USD Million)
  • Table 71 Japan Activated Clotting Time Testing market, by Product, 2021 - 2033 (USD Million)
  • Table 72 Japan Activated Clotting Time Testing market, by Test Type, 2021 - 2033 (USD Million)
  • Table 73 Japan Activated Clotting Time Testing market, by Application, 2021 - 2033 (USD Million)
  • Table 74 Japan Activated Clotting Time Testing market, by End Use, 2021 - 2033 (USD Million)
  • Table 75 China Activated Clotting Time Testing market, by Product, 2021 - 2033 (USD Million)
  • Table 76 China Activated Clotting Time Testing market, by Test Type 2021 - 2033 (USD Million)
  • Table 77 China Activated Clotting Time Testing market, by Application 2021 - 2033 (USD Million)
  • Table 78 China Activated Clotting Time Testing market, by End Use, 2021 - 2033 (USD Million)
  • Table 79 India Activated Clotting Time Testing market, by Product, 2021 - 2033 (USD Million)
  • Table 80 India Activated Clotting Time Testing market, by Test Type, 2021 - 2033 (USD Million)
  • Table 81 India Activated Clotting Time Testing market, by Application, 2021 - 2033 (USD Million)
  • Table 82 India Activated Clotting Time Testing market, by End Use, 2021 - 2033 (USD Million)
  • Table 83 Australia Activated Clotting Time Testing market, by Product, 2021 - 2033 (USD Million)
  • Table 84 Australia Activated Clotting Time Testing market, by Test Type, 2021 - 2033 (USD Million)
  • Table 85 Australia Activated Clotting Time Testing market, by Application, 2021 - 2033 (USD Million)
  • Table 86 Australia Activated Clotting Time Testing market, by End Use, 2021 - 2033 (USD Million)
  • Table 87 South Korea Activated Clotting Time Testing market, by Product, 2021 - 2033 (USD Million)
  • Table 88 South Korea Activated Clotting Time Testing market, by Test Type, 2021 - 2033 (USD Million)
  • Table 89 South Korea Activated Clotting Time Testing market, by Application, 2021 - 2033 (USD Million)
  • Table 90 South Korea Activated Clotting Time Testing market, by End Use, 2021 - 2033 (USD Million)
  • Table 91 Thailand Activated Clotting Time Testing market, by Product, 2021 - 2033 (USD Million)
  • Table 92 Thailand Activated Clotting Time Testing market, by Test Type, 2021 - 2033 (USD Million)
  • Table 93 Thailand Activated Clotting Time Testing market, by Application, 2021 - 2033 (USD Million)
  • Table 94 Thailand Activated Clotting Time Testing market, by End Use, 2021 - 2033 (USD Million)
  • Table 95 Rest of Asia Pacific Activated Clotting Time Testing market, by Product, 2021 - 2033 (USD Million)
  • Table 96 Rest of Asia Pacific Activated Clotting Time Testing market, by Test Type, 2021 - 2033 (USD Million)
  • Table 97 Rest of Asia Pacific Activated Clotting Time Testing market, by Application, 2021 - 2033 (USD Million)
  • Table 98 Rest of Asia Pacific Activated Clotting Time Testing market, by End Use, 2021 - 2033 (USD Million)
  • Table 99 Latin America Activated Clotting Time Testing market, by Country, 2021 - 2033 (USD Million)
  • Table 100 Latin America Activated Clotting Time Testing market, by Product, 2021 - 2033 (USD Million)
  • Table 101 Latin America Activated Clotting Time Testing market, by Test Type, 2021 - 2033 (USD Million)
  • Table 102 Latin America Activated Clotting Time Testing market, by Application, 2021 - 2033 (USD Million)
  • Table 103 Latin America Activated Clotting Time Testing market, by End Use, 2021 - 2033 (USD Million)
  • Table 104 Brazil Activated Clotting Time Testing market, by Product, 2021 - 2033 (USD Million)
  • Table 105 Brazil Activated Clotting Time Testing market, by Test Type, 2021 - 2033 (USD Million)
  • Table 106 Brazil Activated Clotting Time Testing market, by Application, 2021 - 2033 (USD Million)
  • Table 107 Brazil Activated Clotting Time Testing market, by End Use, 2021 - 2033 (USD Million)
  • Table 108 Argentina Activated Clotting Time Testing market, by Product, 2021 - 2033 (USD Million)
  • Table 109 Argentina Activated Clotting Time Testing market, by Test Type, 2021 - 2033 (USD Million)
  • Table 110 Argentina Activated Clotting Time Testing market, by Application, 2021 - 2033 (USD Million)
  • Table 111 Argentina Activated Clotting Time Testing market, by End Use, 2021 - 2033 (USD Million)
  • Table 112 Rest of Latin America Activated Clotting Time Testing market, by Product, 2021 - 2033 (USD Million)
  • Table 113 Rest of Latin America Activated Clotting Time Testing market, by Test Type, 2021 - 2033 (USD Million)
  • Table 114 Rest of Latin America Activated Clotting Time Testing market, by Application, 2021 - 2033 (USD Million)
  • Table 115 Rest of Latin America Activated Clotting Time Testing market, by End Use, 2021 - 2033 (USD Million)
  • Table 116 Middle East & Africa Activated Clotting Time Testing market, by Country, 2021 - 2033 (USD Million)
  • Table 117 Middle East & Africa Activated Clotting Time Testing market, by Product, 2021 - 2033 (USD Million)
  • Table 118 Middle East & Africa Activated Clotting Time Testing market, by Test Type, 2021 - 2033 (USD Million)
  • Table 119 Middle East & Africa Activated Clotting Time Testing market, by Application, 2021 - 2033 (USD Million)
  • Table 120 Middle East & Africa Activated Clotting Time Testing market, by End Use, 2021 - 2033 (USD Million)
  • Table 121 South Africa Activated Clotting Time Testing market, by Product, 2021 - 2033 (USD Million)
  • Table 122 South Africa Activated Clotting Time Testing market, by Test Type, 2021 - 2033 (USD Million)
  • Table 123 South Africa Activated Clotting Time Testing market, by Application, 2021 - 2033 (USD Million
  • Table 124 South Africa Activated Clotting Time Testing market, by End Use, 2021 - 2033 (USD Million))
  • Table 125 Saudi Arabia Activated Clotting Time Testing market, by Product, 2021 - 2033 (USD Million)
  • Table 126 Saudi Arabia Activated Clotting Time Testing market, by Test Type, 2021 - 2033 (USD Million)
  • Table 127 Saudi Arabia Activated Clotting Time Testing market, by Application, 2021 - 2033 (USD Million)
  • Table 128 Saudi Arabia Activated Clotting Time Testing market, by End Use, 2021 - 2033 (USD Million)
  • Table 129 UAE Activated Clotting Time Testing market, by Product, 2021 - 2033 (USD Million)
  • Table 130 UAE Activated Clotting Time Testing market, by Test Type, 2021 - 2033 (USD Million)
  • Table 131 UAE Activated Clotting Time Testing market, by Application, 2021 - 2033 (USD Million)
  • Table 132 UAE Activated Clotting Time Testing market, by End Use, 2021 - 2033 (USD Million)
  • Table 133 Kuwait Activated Clotting Time Testing market, by Product, 2021 - 2033 (USD Million)
  • Table 134 Kuwait Activated Clotting Time Testing market, by Test Type, 2021 - 2033 (USD Million)
  • Table 135 Kuwait Activated Clotting Time Testing market, by Application, 2021 - 2033 (USD Million)
  • Table 136 Kuwait Activated Clotting Time Testing market, by End Use, 2021 - 2033 (USD Million)
  • Table 137 Rest of MEA Activated Clotting Time Testing market, by Product, 2021 - 2033 (USD Million)
  • Table 138 Rest of MEA Activated Clotting Time Testing market, by Test Type, 2021 - 2033 (USD Million)
  • Table 139 Rest of MEA Activated Clotting Time Testing market, by Application, 2021 - 2033 (USD Million)
  • Table 140 Rest of MEA Activated Clotting Time Testing market, by End Use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Information procurement
  • Fig. 2 Primary research pattern
  • Fig. 3 Market research approaches
  • Fig. 4 Value chain-based sizing & forecasting
  • Fig. 5 Market formulation & validation
  • Fig. 6 Activated Clotting Time Testing market segmentation
  • Fig. 7 Market driver analysis (current & future impact)
  • Fig. 8 Market restraint analysis (current & future impact)
  • Fig. 9 SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 10 Porter's five forces analysis
  • Fig. 11 Activated clotting time testing market, Product outlook key takeaways (USD Million), 2025 & 2033
  • Fig. 12 Activated clotting time testing market, Product movement analysis (USD Million), 2025 & 2033
  • Fig. 13 ACT analyzers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 14 Consumables (cartridges, tubes, reagents) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 15 Activated clotting time testing market, test type outlook key takeaways (USD Million), 2025 & 2033
  • Fig. 16 Activated clotting time testing market, test type movement analysis (USD Million), 2025 & 2033
  • Fig. 17 High-range ACT tests market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 18 Low-range ACT tests market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 19 Activated clotting time testing market, Application outlook key takeaways (USD Million), 2025 & 2033
  • Fig. 20 Activated clotting time testing market, application movement analysis (USD Million), 2025 & 2033
  • Fig. 21 Cardiovascular surgery market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 Interventional cardiology market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 23 Extracorporeal Membrane Oxygenation (ECMO) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 Hemodialysis market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Activated clotting time testing market, end use outlook key takeaways (USD Million), 2025 & 2033
  • Fig. 27 Activated clotting time testing market, end use movement analysis (USD Million), 2025 & 2033
  • Fig. 28 Hospital market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 29 Ambulatory surgical centers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 Clinical laboratories market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 31 Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 32 North America activated clotting time testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 33 U.S. activated clotting time testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 Canada activated clotting time testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Mexico activated clotting time testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 Europe activated clotting time testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 UK activated clotting time testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 Germany activated clotting time testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 France activated clotting time testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 40 Spain activated clotting time testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 Italy activated clotting time testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 Denmark activated clotting time testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 Sweden activated clotting time testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 44 Norway activated clotting time testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 45 Rest of Europe activated clotting time testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 46 Asia Pacific activated clotting time testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 47 China activated clotting time testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 48 Japan activated clotting time testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 49 India activated clotting time testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 50 South Korea activated clotting time testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 51 Australia activated clotting time testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 52 Thailand activated clotting time testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 53 Rest of Asia Pacific activated clotting time testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 54 Latin America activated clotting time testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 55 Brazil activated clotting time testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 56 Argentina activated clotting time testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 57 Rest of Latin America activated clotting time testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 58 Middle East and Africa activated clotting time testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 59 South Africa activated clotting time testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 60 Saudi Arabia activated clotting time testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 61 UAE activated clotting time testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 62 Kuwait activated clotting time testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 63 Rest of MEA activated clotting time testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 64 List of key emerging company's
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!